NEW YORK--(BUSINESS WIRE)-- Levi & Korsinsky announces it has commenced an investigation of Genocea Biosciences, Inc. (NASDAQ:GNCA) concerning possible violations of federal securities laws. On September 25, 2017, Genocea disclosed that it was halting spending and activities on GEN-003 and exploring strategic alternatives for the drug. The Company also announced that it was cutting 40% of its workforce. To obtain additional information, go to:
or contact Joseph E. Levi, Esq. either via email at firstname.lastname@example.org or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171101006649/en/
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
Toll Free: 877-363-5972
Source: Levi & Korsinsky, LLP